Nicorette Quickmist (Nicotine)

Nicotine, the active ingredient in Nicorette Quickmist, is a nicotine replacement therapy presented as a spray for oromucosal use. It helps adults who want to quit smoking by reducing withdrawal symptoms and cravings. GNH USA supplies Nicorette Quickmist as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicorette Quickmist, a nicotine replacement therapy, is used in smoking cessation to manage nicotine dependence.

- Smoking cessation: assists adult smokers in reducing cravings and withdrawal symptoms during quit attempts. - Relapse prevention: supports individuals who have recently quit to maintain abstinence. - Nicotine dependence: provides controlled nicotine delivery to replace cigarettes.

Nicorette Quickmist may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Throat irritation: mild soreness or scratchiness in the throat. - Mouth irritation: tingling or burning sensation in the oral cavity. - Cough: occasional dry cough after use. - Nausea: feeling of queasiness. - Headache: mild to moderate headache. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Chest pain: unexpected discomfort in the chest area. - Rapid heartbeat: palpitations or increased heart rate. - Severe skin rash: widespread or blistering rash. - Mouth ulcers: painful sores in the mouth. - Hypotension: unusually low blood pressure.

When using Nicorette Quickmist, consider the following safety measures.

- Assess cardiovascular status: avoid use in patients with recent myocardial infarction or uncontrolled hypertension. - Evaluate nicotine tolerance: do not exceed recommended usage if the user is nicotine‑naïve. - Monitor for psychiatric symptoms: be alert to mood changes or increased anxiety. - Avoid use in children and adolescents: product is intended for adult smokers only. - Do not combine with other nicotine products: concurrent use may increase risk of overdose. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Nicorette Quickmist can interact with certain medications and substances.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): additive sympathomimetic effects may increase blood pressure. - Other nicotine products: concurrent use can lead to nicotine toxicity. - Bupropion: heightened seizure risk when combined.

Moderate Interactions (Monitor Closely): - Caffeine: may exacerbate jitteriness or palpitations. - Alcohol: can enhance nicotine’s cardiovascular effects. - Certain antihypertensives: nicotine may reduce their efficacy, requiring monitoring.